128 Participants Needed

ESP Block for Pain After Kidney Stone Surgery

JB
AP
Overseen ByAimee Pehrson
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Tennessee Medical Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores the effectiveness of a special type of pain relief, the erector spinae (ESP) block, after kidney stone surgery. Researchers aim to determine if it reduces morphine use and pain compared to a simple saline injection. Participants will receive either the ESP block with ropivacaine (a numbing medicine) and dexamethasone (an anti-inflammatory) or just a saline injection. This study may suit adults scheduled for non-emergency kidney stone surgery who do not regularly use opioids. As an unphased trial, it offers participants the chance to contribute to innovative pain management research.

Do I have to stop taking my current medications for this trial?

The trial protocol does not specify whether you need to stop taking your current medications. However, if you have been using opioids for more than 90 days in the past year, you cannot participate.

What prior data suggests that the erector spinae block is safe for reducing pain after kidney stone surgery?

Research has shown that the erector spinae plane (ESP) block is generally safe for managing pain after kidney stone surgery. Studies have found that patients receiving an ESP block experience good pain relief with few side effects. In one study with 68 patients, the ESP block was well-tolerated.

The anesthetic used in the block, ropivacaine, is safe when used properly. Dexamethasone, a steroid added to reduce swelling, is also commonly used and has a good safety record. Reports suggest that these treatments together effectively manage pain without major side effects.

While the ESP block works well, its pain-relieving effects are usually short-term. Overall, the treatment is considered safe, and side effects are rare.12345

Why are researchers excited about this trial?

Researchers are excited about the ESP Block with ropivacaine and dexamethasone for post-kidney stone surgery pain because it offers a targeted approach to pain management. Unlike opioids, which are commonly used and can lead to significant side effects and dependency, this method involves a local anesthetic technique that directly numbs the nerves near the spine, providing pain relief right where it's needed. Additionally, combining ropivacaine with dexamethasone may enhance and prolong the pain relief effect without the systemic impact of traditional pain medications. This innovative approach aims to reduce reliance on opioids, offering a potentially safer and more effective pain management solution.

What evidence suggests that the ESP block is effective for reducing pain after kidney stone surgery?

In this trial, participants in the ESP Group will receive an erector spinae plane (ESP) block with ropivacaine and dexamethasone. Research shows this method can effectively reduce pain and lessen the need for painkillers after kidney stone surgery. One study found that patients who received an ESP block used fewer opioids and experienced less pain post-surgery. Another study confirmed that this block provides significant pain relief soon after surgery. Additionally, the ESP block has demonstrated long-lasting pain control after these procedures. These findings suggest that the ESP block might help manage pain and reduce opioid use in patients recovering from kidney stone surgery.678910

Who Is on the Research Team?

JB

Jason Buehler, MD

Principal Investigator

University of Tennessee Medical Center

Are You a Good Fit for This Trial?

This trial is for English-speaking adults over 18 who are having non-emergency kidney stone surgery (percutaneous nephrolithotomy) during weekdays. They must be able to understand and explain the consent process, and women of childbearing age need a negative pregnancy test.

Inclusion Criteria

Ability to understand and teach back consent for the procedure
Willingness to sign consent for procedure
I can have children and will provide a negative pregnancy test.
See 2 more

Exclusion Criteria

Opioid use >90 days in the year leading up to surgery
Pregnancy or breastfeeding
I do not have any health conditions that would make the trial unsafe for me.
See 6 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Treatment

Participants undergo percutaneous nephrolithotomy and receive either an ESP block or a control block

1 day
1 visit (in-person)

Immediate Post-operative Monitoring

Participants are monitored for opioid consumption and pain levels using VAS scores in the first 24 hours post-surgery

24 hours

Follow-up

Participants are monitored for recovery quality and opioid use at 24 hours, 48 hours, 7 days, and 30 days post-surgery

30 days
4 visits (in-person or virtual)

What Are the Treatments Tested in This Trial?

Interventions

  • Dexamethasone
  • Erector Spinae Plane Block
  • Ropivacaine 0.5% Injectable Solution
Trial Overview The study tests if an ESP block with Ropivacaine and Dexamethasone reduces painkiller needs after kidney stone surgery compared to a saline solution control. It also looks at its effect on reported pain levels post-surgery.
How Is the Trial Designed?
2Treatment groups
Active Control
Placebo Group
Group I: ESP GroupActive Control3 Interventions
Group II: Sham GroupPlacebo Group1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Tennessee Medical Center

Lead Sponsor

Trials
7
Recruited
450+

Published Research Related to This Trial

Adding 20 mg of nalbuphine to ropivacaine in an erector spinae plane block significantly prolongs the time to first opioid demand after percutaneous nephrolithotomy, with a median time of 8.70 hours compared to 2.90 hours for ropivacaine alone.
The combination of nalbuphine and ropivacaine also reduces postoperative morphine consumption, indicating enhanced analgesic efficacy without compromising safety, as VAS pain scores remained comparable across all groups.
Analgesic Efficacy of Nalbuphine as an Adjuvant to Ropivacaine in Erector Spinae Plane Block for Percutaneous Nephrolithotomy: A Randomized, Double-Blinded, Clinical Trial.Sun, M., Wu, Z., Wang, R., et al.[2023]
The erector spinae plane block (ESPB) significantly reduced the need for opioids post-surgery, with lower total morphine consumption in the first 48 hours compared to intravenous patient-controlled analgesia (PCA).
Patients receiving ESPB experienced longer time to first analgesic request and lower pain scores at rest and during movement, indicating more effective pain management after open nephrectomy for renal malignancies.
Ultrasound Guided Continuous Erector Spinae Plane Block versus Patient Controlled Analgesia in Open Nephrectomy for Renal Malignancies: A Randomized Controlled Study.Abdelgalil, AS., Ahmed, AM., Gamal, RM., et al.[2022]
In a study of 60 patients undergoing percutaneous nephrolithotomy, the erector spinae plane block (ESPB) significantly reduced postoperative pain levels compared to the control group, as measured by the visual analog scale (VAS) at multiple time points (0, 6, and 24 hours).
Patients receiving the ESPB also experienced better respiratory outcomes, with a lower incidence of agitation and improved peak expiratory flow rates (PEFR) compared to those who only received intravenous analgesia.
Should the Erector Spinae Plane Block Be Applied in the Pain Management of Percutaneous Nephrolithotomy?Unal, S., Baskan, S., Guven Aytac, B., et al.[2022]

Citations

The Efficacy of Erector Spinae Plane Block for Patients ...Our results showed that erector spinae plane block (ESPB) reduces intraoperative and postoperative opioid consumption and postoperative pain ...
Erector Spinae Plane Block for Perioperative Analgesia ...Erector spinae plane block is an effective pain treatment after percutaneous nephrolithotomy but only for a very short postoperative period.
Comparison of the efficacy of erector spinae plane block...ESP block is a very effective and safe technique to provide prolonged duration of postoperative analgesia following PCNL. Peritubal local anesthetic ...
Evaluation of erector spinae plane block in patients ...This study aimed to investigate the efficacy of the erector spinae plane block (ESPB) in reducing both intraoperative opioid consumption and ...
Comparison Between External Oblique Intercostal Block ...The aim of this study is to compare the post-operative analgesic effect of USG unilateral External oblique intercostal (EOI) block with Erector spinae plane ...
Erector Spinae Plane Block for Perioperative Analgesia ...Erector spinae plane block is an effective pain treatment after percutaneous nephrolithotomy but only for a very short postoperative period.
Efficacy of erector spinae plane block for postoperative ...We performed a systematic review and meta-analysis on the use of ESPB for perioperative analgesia in PCNL for renal stone disease. A systematic literature ...
Erector Spinae Plane Block for Perioperative Analgesia ...The aim of our study was to test the efficacy and safety of erector spinae plane block after percutaneous nephrolithotomy. We analyzed 68 patients, 34 of whom ...
Erector Spinae Plane Block for Perioperative Analgesia ...The aim of our study was to test the efficacy and safety of erector spinae plane block after percutaneous nephrolithotomy. We analyzed 68 ...
Erector spinae plane block with catheter for management of...Outcomes: No opioid or other pain medications, other than the local anesthetic solution given in the ESPCs, were used during the intra-operative ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security